37073143|t|Cholinesterase Inhibitory and In Silico Toxicity Assessment of Thirty-Four Isoquinoline Alkaloids - Berberine as the Lead Compound.
37073143|a|BACKGROUND: Cholinesterase (ChE) inhibitors used currently in clinics for the treatment of Alzheimer's disease (AD) are the most prescribed drug class with nitrogen-containing chemical formula. Galanthamine, the latest generation anti-ChE drug, contains an isoquinoline structure. OBJECTIVE: The aim of the current study was to investigate the inhibitory potential of thirty-four isoquinoline alkaloids, e.g. (-)-adlumidine, beta-allocryptopine, berberine, (+)-bicuculline, (-)-bicuculline, (+)-bulbocapnine, (-)-canadine, (+-)-chelidimerine, corydaldine, (+-)-corydalidzine, (-)-corydalmine, (+)-cularicine, dehydrocavidine, (+)-fumariline, (-)-fumarophycine, (+)-alpha-hydrastine, (+)-isoboldine, 13-methylcolumbamine, (-)-norjuziphine, norsanguinarine, (-)-ophiocarpine, (-)-ophiocarpine-N-oxide, oxocularine, oxosarcocapnine, palmatine, (+)-parfumine, protopine, (+)-reticuline, sanguinarine, (+)-scoulerine, (+-)-sibiricine, (+-)-sibiricine acetate, (-)-sinactine, and (-)-stylopine isolated from several Fumaria (fumitory) and Corydalis species towards acetyl- (AChE) and butyrylcholinesterase (BChE) by microtiter plate assays. The alkaloids with strong ChE inhibition were proceeded to molecular docking simulations as well as in silico toxicity screening for their mutagenic capacity through VEGA QSAR (AMES test) consensus model and VEGA platform as statistical approaches. The inputs were evaluated in a simplified molecular input-line entry system (SMILES). RESULTS: ChE inhibition assays indicated that the highest AChE inhibition was caused by berberine (IC50: 0.72 +- 0.04 microg/mL), palmatine (IC50: 6.29 +- 0.61 microg/mL), beta-allocryptopine (IC50: 10.62 +- 0.45 microg/mL), (-)-sinactine (IC50: 11.94 +- 0.44 microg/mL), and dehydrocavidine (IC50: 15.01 +- 1.87 microg/mL) as compared to that of galanthamine (IC50: 0.74 +- 0.01 microg/mL), the reference drug with isoquinoline skeleton. Less number of the tested alkaloids exhibited notable BChE inhibition. Among them, berberine (IC50: 7.67 +- 0.36 microg/mL) and (-)-corydalmine (IC50: 7.78 +- 0.38 microg/mL) displayed a stronger inhibition than that of galanthamine (IC50: 12.02 +- 0.25 microg/mL). The mutagenic activity was shown for beta-allocryptopine, (+)- and (-)-bicuculline, (+-)-corydalidzine, (-)-corydalmine, (+)-cularicine, (-)-fumarophycine, (-)-norjuziphine, (-)-ophiocarpine-N-oxide, (+)-scoulerine, (-)-sinactine, and (-)-stylopine by means of in silico experiments. The results obtained by molecular docking simulations of berberine, palmatine, and (-)-corydalmine suggested that the estimated free ligand-binding energies of these compounds inside the binding domains of their targets are reasonable to make them capable of establishing strong polar and nonpolar bonds with the atoms of the active site amino acids. CONCLUSION: Our findings revealed that berberine, palmatin, and (-)-corydalmine stand out as the most promising isoquinoline alkaloids in terms of ChE inhibition. Among them, berberine has displayed a robust dual inhibition against both ChEs and could be evaluated further as a lead compound for AD.
37073143	0	14	Cholinesterase	Gene	590
37073143	40	48	Toxicity	Disease	MESH:D064420
37073143	75	97	Isoquinoline Alkaloids	Chemical	-
37073143	100	109	Berberine	Chemical	MESH:D001599
37073143	144	158	Cholinesterase	Gene	590
37073143	223	242	Alzheimer's disease	Disease	MESH:D000544
37073143	244	246	AD	Disease	MESH:D000544
37073143	288	296	nitrogen	Chemical	MESH:D009584
37073143	326	338	Galanthamine	Chemical	MESH:D005702
37073143	389	401	isoquinoline	Chemical	MESH:C039109
37073143	512	534	isoquinoline alkaloids	Chemical	-
37073143	545	555	adlumidine	Chemical	-
37073143	557	576	beta-allocryptopine	Chemical	-
37073143	578	587	berberine	Chemical	MESH:D001599
37073143	593	604	bicuculline	Chemical	MESH:D001640
37073143	610	621	bicuculline	Chemical	MESH:D001640
37073143	627	639	bulbocapnine	Chemical	MESH:C083807
37073143	645	653	canadine	Chemical	MESH:C004645
37073143	660	673	chelidimerine	Chemical	MESH:C000467
37073143	675	686	corydaldine	Chemical	-
37073143	693	706	corydalidzine	Chemical	-
37073143	708	723	(-)-corydalmine	Chemical	MESH:C058198
37073143	729	739	cularicine	Chemical	-
37073143	741	756	dehydrocavidine	Chemical	MESH:C011188
37073143	762	772	fumariline	Chemical	MESH:C049095
37073143	778	791	fumarophycine	Chemical	-
37073143	797	813	alpha-hydrastine	Chemical	-
37073143	819	829	isoboldine	Chemical	MESH:C464744
37073143	831	851	13-methylcolumbamine	Chemical	-
37073143	857	869	norjuziphine	Chemical	MESH:C438020
37073143	871	886	norsanguinarine	Chemical	MESH:C483650
37073143	892	904	ophiocarpine	Chemical	MESH:C012464
37073143	910	930	ophiocarpine-N-oxide	Chemical	-
37073143	932	943	oxocularine	Chemical	-
37073143	945	960	oxosarcocapnine	Chemical	-
37073143	962	971	palmatine	Chemical	MESH:C005413
37073143	975	986	)-parfumine	Chemical	-
37073143	988	997	protopine	Chemical	MESH:C009093
37073143	1015	1027	sanguinarine	Chemical	MESH:C005705
37073143	1033	1043	scoulerine	Chemical	MESH:C010941
37073143	1089	1100	)-sinactine	Chemical	-
37073143	1110	1119	stylopine	Chemical	MESH:C014212
37073143	1200	1204	AChE	Gene	43
37073143	1271	1280	alkaloids	Chemical	MESH:D000470
37073143	1377	1385	toxicity	Disease	MESH:D064420
37073143	1660	1664	AChE	Gene	43
37073143	1690	1699	berberine	Chemical	MESH:D001599
37073143	1732	1741	palmatine	Chemical	MESH:C005413
37073143	1774	1793	beta-allocryptopine	Chemical	-
37073143	1829	1840	)-sinactine	Chemical	-
37073143	1878	1893	dehydrocavidine	Chemical	MESH:C011188
37073143	1949	1961	galanthamine	Chemical	MESH:D005702
37073143	2018	2030	isoquinoline	Chemical	MESH:C039109
37073143	2067	2076	alkaloids	Chemical	MESH:D000470
37073143	2124	2133	berberine	Chemical	MESH:D001599
37073143	2169	2184	(-)-corydalmine	Chemical	MESH:C058198
37073143	2261	2273	galanthamine	Chemical	MESH:D005702
37073143	2344	2363	beta-allocryptopine	Chemical	-
37073143	2378	2389	bicuculline	Chemical	MESH:D001640
37073143	2396	2409	corydalidzine	Chemical	-
37073143	2411	2426	(-)-corydalmine	Chemical	MESH:C058198
37073143	2432	2442	cularicine	Chemical	-
37073143	2448	2461	fumarophycine	Chemical	-
37073143	2467	2479	norjuziphine	Chemical	MESH:C438020
37073143	2485	2505	ophiocarpine-N-oxide	Chemical	-
37073143	2511	2521	scoulerine	Chemical	MESH:C010941
37073143	2525	2536	)-sinactine	Chemical	-
37073143	2546	2555	stylopine	Chemical	MESH:C014212
37073143	2648	2657	berberine	Chemical	MESH:D001599
37073143	2659	2668	palmatine	Chemical	MESH:C005413
37073143	2674	2689	(-)-corydalmine	Chemical	MESH:C058198
37073143	2981	2990	berberine	Chemical	MESH:D001599
37073143	2992	3000	palmatin	Chemical	-
37073143	3006	3021	(-)-corydalmine	Chemical	MESH:C058198
37073143	3054	3076	isoquinoline alkaloids	Chemical	-
37073143	3117	3126	berberine	Chemical	MESH:D001599
37073143	3179	3183	ChEs	Disease	
37073143	3238	3240	AD	Disease	MESH:D000544
37073143	Negative_Correlation	MESH:D005702	MESH:D000544
37073143	Negative_Correlation	MESH:C014212	MESH:D000544
37073143	Negative_Correlation	MESH:D000544	590
37073143	Negative_Correlation	MESH:D009584	MESH:D000544

